Free Trial

Bridgefront Capital LLC Invests $989,000 in The Cooper Companies, Inc. (NASDAQ:COO)

Cooper Companies logo with Medical background

Bridgefront Capital LLC purchased a new stake in The Cooper Companies, Inc. (NASDAQ:COO - Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor purchased 10,761 shares of the medical device company's stock, valued at approximately $989,000.

A number of other institutional investors have also added to or reduced their stakes in the company. Byrne Asset Management LLC acquired a new position in shares of Cooper Companies in the 4th quarter valued at $33,000. OFI Invest Asset Management bought a new position in shares of Cooper Companies in the 4th quarter valued at about $34,000. New Age Alpha Advisors LLC acquired a new stake in shares of Cooper Companies in the 4th quarter valued at approximately $38,000. Covestor Ltd grew its position in shares of Cooper Companies by 35.5% in the 4th quarter. Covestor Ltd now owns 458 shares of the medical device company's stock valued at $42,000 after acquiring an additional 120 shares during the period. Finally, West Financial Advisors LLC acquired a new stake in shares of Cooper Companies in the fourth quarter valued at approximately $49,000. 24.39% of the stock is owned by institutional investors and hedge funds.

Cooper Companies Stock Performance

NASDAQ:COO traded down $0.65 during mid-day trading on Friday, reaching $82.27. The company's stock had a trading volume of 1,265,544 shares, compared to its average volume of 1,443,359. The stock has a market cap of $16.45 billion, a P/E ratio of 42.19, a PEG ratio of 2.25 and a beta of 1.08. The firm's fifty day moving average price is $80.71 and its two-hundred day moving average price is $91.19. The Cooper Companies, Inc. has a 12-month low of $69.81 and a 12-month high of $112.38. The company has a current ratio of 1.91, a quick ratio of 1.12 and a debt-to-equity ratio of 0.32.

Cooper Companies (NASDAQ:COO - Get Free Report) last announced its quarterly earnings data on Thursday, March 6th. The medical device company reported $0.92 earnings per share (EPS) for the quarter, hitting analysts' consensus estimates of $0.92. Cooper Companies had a net margin of 10.07% and a return on equity of 9.38%. The firm had revenue of $964.70 million during the quarter, compared to analysts' expectations of $981.25 million. On average, equities analysts forecast that The Cooper Companies, Inc. will post 3.98 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Several research analysts have recently commented on the stock. Citigroup lowered their target price on shares of Cooper Companies from $115.00 to $110.00 and set a "buy" rating on the stock in a report on Friday, March 7th. Needham & Company LLC restated a "hold" rating on shares of Cooper Companies in a research report on Friday, March 7th. BNP Paribas upgraded Cooper Companies to a "hold" rating in a report on Thursday, March 13th. JPMorgan Chase & Co. lowered their price objective on Cooper Companies from $120.00 to $110.00 and set an "overweight" rating for the company in a research report on Friday, March 7th. Finally, Stifel Nicolaus reduced their price target on shares of Cooper Companies from $115.00 to $105.00 and set a "buy" rating for the company in a report on Friday, March 7th. Four investment analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. According to data from MarketBeat, Cooper Companies presently has a consensus rating of "Moderate Buy" and a consensus target price of $110.25.

Check Out Our Latest Stock Analysis on Cooper Companies

Cooper Companies Company Profile

(Free Report)

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.

Featured Articles

Institutional Ownership by Quarter for Cooper Companies (NASDAQ:COO)

Should You Invest $1,000 in Cooper Companies Right Now?

Before you consider Cooper Companies, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cooper Companies wasn't on the list.

While Cooper Companies currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

5 Blowout Earnings Winners That Could Soar Even Higher
5 Stocks You’ve Never Heard Of That I’m Buying Nonstop in 2025
3 Sectors With Massive Momentum You Can’t Afford to Miss

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines